Insys Issues Clarify Statement: Says No Single Physician Has Written 5%+ of Total Subsys Scripts
May 12, 2014 at 15:32 PM EDT
Insys Therapeutics, Inc. (NASDAQ: INSY) today issued a clarifying statement regarding its Subsys® (fentanyl sublingual spray) product. ...
